Pre-silencing of genes involved in the electron transport chain (ETC) pathway is associated with responsiveness to abatacept in rheumatoid arthritis

Maria Antonietta D'Agostino, C. Derambure, G. Dzangue-Tchoupou, C. Berard, N. Vergne, M. Hiron, M. A. D'Agostino, P. Musette, O. Vittecoq, T. Lequerré

Risultato della ricerca: Contributo in rivistaArticolo in rivista

9 Citazioni (Scopus)

Abstract

Background: In the current context of personalized medicine, one of the major challenges in the management of rheumatoid arthritis (RA) is to identify biomarkers that predict drug responsiveness. From the European APPRAISE trial, our main objective was to identify a gene expression profile associated with responsiveness to abatacept (ABA) + methotrexate (MTX) and to understand the involvement of this signature in the pathophysiology of RA. Methods: Whole human genome microarrays (4 × 44 K) were performed from a first subset of 36 patients with RA. Data validation by quantitative reverse-transcription (qRT)-PCR was performed from a second independent subset of 32 patients with RA. Gene Ontology and WikiPathways database allowed us to highlight the specific biological mechanisms involved in predicting response to ABA/MTX. Results: From the first subset of 36 patients with RA, a combination including 87 transcripts allowed almost perfect separation between responders and non-responders to ABA/MTX. Next, the second subset of patients 32 with RA allowed validation by qRT-PCR of a minimal signature with only four genes. This latter signature categorized 81% of patients with RA with 75% sensitivity, 85% specificity and 85% negative predictive value. This combination showed a significant enrichment of genes involved in electron transport chain (ETC) pathways. Seven transcripts from ETC pathways (NDUFA6, NDUFA4, UQCRQ, ATP5J, COX7A2, COX7B, COX6A1) were significantly downregulated in responders versus non-responders to ABA/MTX. Moreover, dysregulation of these genes was independent of inflammation and was specific to ABA response. Conclusion: Pre-silencing of ETC genes is associated with future response to ABA/MTX and might be a crucial key to susceptibility to ABA response.
Lingua originaleEnglish
pagine (da-a)109-109
Numero di pagine1
RivistaARTHRITIS RESEARCH & THERAPY
Volume19
DOI
Stato di pubblicazionePubblicato - 2017

Keywords

  • Abatacept
  • Abatacept response
  • Adult
  • Aged
  • Antirheumatic Agents
  • Arthritis, Rheumatoid
  • Biomarkers
  • Drug Resistance
  • Electron Transport Chain Complex Proteins
  • Female
  • Gene Expression Profiling
  • Humans
  • Male
  • Methotrexate
  • Microarray
  • Middle Aged
  • Mitochondria
  • Oxydative stress
  • Rheumatoid arthritis
  • Transcriptome

Fingerprint

Entra nei temi di ricerca di 'Pre-silencing of genes involved in the electron transport chain (ETC) pathway is associated with responsiveness to abatacept in rheumatoid arthritis'. Insieme formano una fingerprint unica.

Cita questo